Mountain View and San Francisco, CA, April
27, 2006
IMPAC Medical Systems, Inc., an Elekta company and a leading
provider of oncology information technology (IT) solutions, and
OTN, a leading specialty pharmaceutical services company,
announced today a co-marketing alliance in which IMPAC will
become OTN’s preferred oncology electronic medical records (EMR)
vendor. The agreement will enable the two companies to combine
their offerings of inventory management, practice management,
drug distribution and a full-spectrum of oncology information
management solutions to deliver even greater value to their
respective customers. IMPAC and OTN also plan to enhance the
interoperability between their respective systems to optimize
their customers’ ability to provide safe, efficient patient
care.
"OTN has a
15-year history of providing community-based oncologists with a
broad set of products and services that can help increase
practice efficiency and allow more time for patient care,
including our innovative Lynx Technologies solutions suite,"
said John Amos, president and CEO of OTN. "Our new alliance
with IMPAC allows us to now offer our customers an oncology EMR
with multisite functionality and other capabilities that can
help them run their practices as efficiently as possible.”
“IMPAC and OTN have worked together on an
informal basis for several years. Formalizing our relationship
allows us to further refine the workflow capabilities of our
oncology information system for managing patient charting,
scheduling, charge capture, billing and outcomes analysis,” said
Jay Hoey, president and CEO of IMPAC Medical Systems, Inc.
“The complementary suite of oncology-specific IT products and
services offered by IMPAC and OTN presents a compelling solution
for any oncology practice that desires to improve process
efficiency, increase checks and balances, and enhance the
quality of patient care.”
Both IMPAC and OTN will exhibit at the upcoming
2006 American Society of Clinical Oncology (ASCO) Annual
Meeting, which will take place June 2-6 at the Georgia World
Congress Center in Atlanta.
********
For more information, please contact:
Lorna Murdock,
Marketing
Communications Manager
IMPAC Medical Systems, Inc.
Tel: +1 650-623-8937, e-mail:
lmurdock@impac.com
Strategic
Alliance Inquiries:
Robert
Hubbell, Business Development
IMPAC Medical Systems, Inc.
Tel: +1 650-623-3856, e-mail: rhubbell@impac.com
Jan Kenoyer, Director, National and Strategic
Alliances,
Elekta Inc.
Tel: +1 770-670-3062, e-mail: jan.kenoyer@elekta.com
Investor Enquiries:
International: Peter Ejemyr, Group VP Corporate Communications,
Elekta AB
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North
America, Elekta Inc.
Tel: +46 708-783 735, e-mail:
lars.jonsteg@elekta.com
OTN
Inquiries:
Stan Ades, Senior Manager, Strategic Marketing
and Communications,
OTN
Tel: +1 650-246-6622, email: Stan.Ades@myotn.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., an Elekta company, provides
healthcare information technology (IT) solutions that streamline
clinical and business operations across the spectrum of cancer
care. IMPAC’s open integration to multiple healthcare data and
imaging systems offers oncology-specific patient charting and
practice management, as well as best-of-breed systems for
anatomic pathology, clinical laboratory, and cancer registry.
With products that are used in association with diagnosis and
treatment environments through long-term follow-up, IMPAC
provides a comprehensive oncology management solution that helps
improve overall communication, process efficiency, and the
quality of patient care. For more information about IMPAC
products and services, please call 888-GO-IMPAC or visit
www.impac.com.
About
Elekta
Elekta is an international medical-technology Group, providing
meaningful clinical solutions, comprehensive information systems
and services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. With
approx. 1700 employees, Elekta’s corporate headquarters is
located in Stockholm, Sweden and the company is listed on the
Stockholm Stock Exchange under the ticker EKTAb. For more
information about Elekta’s products or services, please visit
www.elekta.com.
About
OTN
OTN, a
One Equity Partners portfolio company, is a leading specialty
pharmaceutical services company that provides pharmaceuticals,
supportive care products and medical/surgical supplies to
physicians who practice in the community-based treatment
setting. OTN provides physicians and their patients with
efficient delivery of medications to treat cancer, as well as
rheumatoid arthritis, infertility and other chronic conditions
requiring the latest intravenous, injectable and oral medicines.
Through its innovative Lynx Technologies, practice management
tools and unsurpassed customer service, OTN helps physicians
improve practice efficiency while enabling them to focus on
providing optimal patient care. Onmark,
a group purchasing organization and an OTN company, offers its
members competitive contracts for oncology drugs and
medical/surgical supplies, practice management tools
and
educational programs.
For more
information, please visit
www.myOTN.com. . |
